The Patent Finder

Terms ending in 2027

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,026,275Compositions, Methods of Use and Preparation of 2,6-Diisopropyl Phenol and Analogs for Ischemic Injury
In force
 · High confidence
Nantbioscience, Inc.In forceHigh confidence
US 8,735,394Combinations and Modes of Administration of Therapeutic Agents and Combination Therapy
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 7,858,782Triazine Derivatives and Their Therapeutical Applications
In force
 · High confidence
Nantbioscience, Inc.In forceHigh confidence
US 8,999,396Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,675,578Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,724,323Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,682,420Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Abraxis Bioscience, LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited